Forrester Research Inc (NASDAQ: FORR) stock closed at $13.27 on 2/12/25 after a major decline of -12.1%. Moreover, exceptionally high trading volume at 468% of normal accompanied the decline. The stock has declined -13.2% during […]
ROLLINS INC (NYSE: ROL) has reported E.P.S. of $0.22 for its fourth fiscal quarter (ending December 31) versus $0.22 for the same period a year ago — flat performance. Relative to the consensus estimate of […]
Biogen Inc (NASDAQ: BIIB) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.83 versus $1.72 for the same period a year ago — an increase of 6%. Relative to the consensus […]
iBio Inc (NYSEAMERICAN: IBIO) stock enjoyed a major increase of 16.1% on 2/12/25. The shares closed at $3.68. Moreover, above average trading volume at 129% of normal accompanied the advance. The stock has risen 15.7% […]
Alkermes Plc (NASDAQ: ALKS) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.90 versus $0.96 for the same period a year ago — a decline of -6%. However, this performance was […]
Martin Marietta Materials Inc. (NYSE: MLM) has reported E.P.S. of $4.81 for its fourth fiscal quarter (ending December 31) versus $4.65 for the same period a year ago — an increase of 3%. This performance […]
IPG Photonics Corp (NASDAQ: IPGP) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.18 versus $0.89 for the same period a year ago — a decline of -80%. This result fell […]
Voyager Therapeutics Inc (NASDAQ: VYGR) stock suffered a major decline of -21.0% on 2/11/25. The shares closed at $4.20. Moreover, trading volume in this decline was exceptionally high at 369% of normal. The stock has […]
Extremely significant negative changes in Nucor Corp (NYSE: NUE) fundamentals have recently occurred: significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2026 decreased significantly, and the consensus estimate […]
On 2/11/25, Axcelis Technologies Inc. (NASDAQ: ACLS) stock suffered a major decline of -12.3%, closing at $59.30. Moreover, exceptionally high trading volume at 372% of normal accompanied the decline. Relative to the market the stock […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research